2022 ESC/ERS Four-Strata PAH Risk Assessment Calculator
Four-Strata Risk Assessment
Enter all three variables to estimate the patient's follow-up PAH risk category.
About the Four-Strata PAH Risk Assessment
The 2022 ESC/ERS four-strata model is a simplified, non-invasive risk-assessment tool for patients with pulmonary arterial hypertension (PAH), particularly during follow-up. It uses WHO-FC, 6MWD, and BNP or NT-proBNP to classify patients into low, intermediate-low, intermediate-high, or high risk.
Each variable is assigned a grade from 1 to 4. The arithmetic mean of the three grades is calculated and rounded to the nearest integer (half values rounded upward) to determine the overall risk category.
Risk grading criteria
| Variable | Low (1) | Intermediate-low (2) | Intermediate-high (3) | High (4) |
|---|---|---|---|---|
| WHO-FC | I or II | — | III | IV |
| 6MWD (m) | >440 | 320–440 | 165–319 | <165 |
| BNP (ng/L) | <50 | 50–199 | 200–800 | >800 |
| NT-proBNP (ng/L) | <300 | 300–649 | 650–1100 | >1100 |
Important application notes
- This model is recommended as a basic risk-stratification tool during follow-up, not as a substitute for comprehensive initial assessment at diagnosis.
- The four-strata model was developed and validated using all three variables. The standard calculation in this tool therefore requires WHO-FC, 6MWD, and BNP or NT-proBNP.
- The key COMPERA 2.0 development cohort consisted of adults with PAH and excluded other forms of pulmonary hypertension, Eisenmenger syndrome, and confirmed or suspected pulmonary veno-occlusive disease/pulmonary capillary haemangiomatosis; applicability outside the studied population requires caution.
- Consider additional clinical information, including right-heart imaging, haemodynamics, disease aetiology, age, sex, comorbidities, and renal function.
- The biomarker cut-offs are assay-specific categories in ng/L. BNP and NT-proBNP are not interchangeable.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.